Omega Healthcare Investors (OHI) Q4 2024 Earnings Call Transcript
OHI earnings call for the period ending December 31, 2024. Omega Healthcare Investors ( OHI -0.68%) Q4 2024 Earnings Call Feb 06, 2025, 10:00 a.m. ET
Expedia Group (EXPE) Q4 2024 Earnings Call Transcript
Good day, everyone, and welcome to the Expedia Group Q4 2024 financial results teleconference. My name is Alex, and I'll be the operator for today's call. [Operator instructions] For opening remarks,
Earnings call transcript: Live Ventures Q4 2024 sees EPS improvement
Live Ventures Inc (NASDAQ:LIVE). reported its earnings for the fourth quarter of 2024, showing a notable improvement in earnings per share (EPS) and a decrease in revenue compared to the previous year.
GoPro (GPRO) Q4 2024 Earnings Call Transcript
GPRO earnings call for the period ending December 31, 2024. GoPro ( GPRO -0.92%) Q4 2024 Earnings Call Feb 06, 2025, 5:00 p.m. ET
Pinterest (PINS) Q4 2024 Earnings Call Transcript
Thank you for attending today's Pinterest Inc. fourth quarter and full year 2024 earnings call. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end.
Boyd Gaming Corporation (BYD) Q4 2024 Earnings Call Transcript
Boyd Gaming Corporation ( NYSE: BYD) Q4 2024 Earnings Conference Call February 6, 2025 5:00 PM ET David Strow – Vice President-Corporate Communications Keith Smith – President and Chief Executive Officer Josh Hirsberg – Executive Vice President and Chief Financial Officer
Wex (WEX) Q4 2024 Earnings Call Transcript
Hello, and welcome to the WEX fourth quarter and full year 2024 earnings call. All lines have been placed on mute to prevent any background noise. Afte
Idexx: Q4 Earnings Snapshot
The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $2.40 per share. The Animal diagnostic and health care company posted revenue of $954.3 million in the period,
IDEXX Laboratories, Inc. (IDXX) Q4 2024 Earnings Call Transcript
Good morning, and welcome to the IDEXX Laboratories' Fourth Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded. Participating in the call this morning are Jay Mazelsky,
Idexx: Q4 EPS, Revenue Beat Forecast
Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.
IDEXX Labs Q4 earnings top estimates, shares edge higher
WESTBROOK, Maine - IDEXX Laboratories, Inc. (NASDAQ:IDXX) reported fourth quarter earnings and revenue that exceeded analyst expectations, sending shares up 0.70% in early trading on Monday.
Farmer Bros. Co. (FARM) Q2 2025 Earnings Call Transcript
Farmer Bros. Co. ( NASDAQ: FARM) Q2 2025 Earnings Conference Call February 6, 2025 5:00 PM ET John Moore - President and CEO Vance Fisher - CFO Gerry Sweeney - ROTH Capital Eric Des Lauriers - ...
ePlus inc. (NASDAQ:PLUS) Q3 2025 Earnings Call Transcript
Operator: Good day, ladies and gentlemen. Welcome to the ePlus Earnings Results Conference Call. As a reminder, this ...
Investing6d
Earnings call transcript: Group 1 Automotive beats Q4 2024 forecasts
Group 1 Automotive's Q4 2024 earnings per share of $10.02 beat the forecasted $9.09 by approximately 10.2%. This positive surprise reflects the company's ability to outperform market expectations ...
The RMR Group Inc. (RMR) Q1 2025 Earnings Call Transcript
Q1 2025 Earnings Conference Call February 6, 2025 10:00 AM ETCompany ParticipantsKevin Barry - Senior Director, ...
Insider Monkey on MSN13h
Accuray Incorporated (NASDAQ:ARAY) Q2 2025 Earnings Call Transcript
Operator: Good day, and welcome to the Accuray Fiscal 2025 Second Quarter Financial Results Conference Call. All participants ...
Investing6d
Earnings call transcript: General Dynamics Q4 2024 sees revenue rise
General Dynamics Corporation (NYSE:GD) reported its financial results for the fourth quarter of 2024, revealing an earnings per share (EPS) of $4.15, which was slightly below the forecast of $4.30.
Earnings call transcript: Medexus Q3 FY2025 shows revenue growth, FDA approval
Medexus Pharmaceuticals reported a strong performance in its Q3 FY2025 earnings call, with notable revenue growth and strategic advancements. The company highlighted a year-over-year increase in ...